Elekta Overview

  • Year Founded
  • 1972

Year Founded

  • Status
  • Public

  • Employees
  • 4,641


  • Stock Symbol
  • EKTA B

Stock Symbol

  • Investments
  • 24

  • Share Price
  • $6.46
  • (As of Friday Closing)

Elekta General Information


Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,000 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and the Asia-Pacific contributing the remainder.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Diagnostic Equipment
Other Industries
Surgical Devices
Other Devices and Supplies
Stock Exchange
Corporate Office
  • Kungstensgatan 18
  • Box 7593
  • 103 93 Stockholm
  • Sweden
+46 08-587 000 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elekta Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.46 $6.32 $6.10 - $8.63 $2.47B 382M 1.32M $0.32

Elekta Financials Summary

In Thousands,
TTM 30-Apr-2024 FY 2024 30-Apr-2024 FY 2023 30-Apr-2023 FY 2022 30-Apr-2022
EV 3,225,904 3,225,904 3,619,566 2,877,742
Revenue 1,702,541 1,702,541 1,608,439 1,632,701
EBITDA 298,619 298,619 237,514 296,844
Net Income 122,342 122,342 89,914 129,512
Total Assets 2,870,883 2,870,883 2,883,718 2,660,389
Total Debt 662,406 662,406 649,440 576,015
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Elekta Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Elekta‘s full profile, request access.

Request a free trial

Elekta Comparisons

HQ Location
Total Raised
Post Valuation
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy
Diagnostic Equipment
Stockholm, Sweden
4,641 As of 2024


piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
00000 0000000 000 00
Palo Alto, CA
0000 As of 0000
000.00 0000-00-00


iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
00000000 0000000
Portage, MI
00000 As of 0000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elekta Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Varian Medical Systems Corporate Backed or Acquired Palo Alto, CA 0000 000000&0
Stryker Formerly VC-backed Portage, MI 00000 00.000 000000000 00.000
Globus Medical Formerly VC-backed Audubon, PA 0000 00000 000000 - 000 00000
Vapotherm Formerly VC-backed Exeter, NH 000 00000 000000000000 00000
Smith & Nephew Corporation Watford, United Kingdom 00000 000 000000000 00 000
You’re viewing 5 of 9 competitors. Get the full list »

Elekta Patents

Elekta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202404249-D0 Mri head coil adaptor Pending 25-Mar-2024
GB-202318444-D0 Fiducial frame and support device Pending 01-Dec-2023
GB-202316473-D0 Device testing Pending 27-Oct-2023
GB-202302955-D0 Machine learning approach to segmentation of an organ image Pending 28-Feb-2023
US-20240123256-A1 Efficient treatment of cranio spinal cancers Pending 12-Oct-2022 A61N5/1043 0
To view Elekta’s complete patent history, request access »

Elekta Executive Team (25)

Name Title Board Seat Contact Info
Gustaf Salford Chief Executive Officer & President
Maurits Wolleswinkel President Linac & Software Solutions
Tobias Hägglöv Chief Financial Officer
Steven Wort Chief Operating Officer
Benoit Sicotte General Manager, Supply Chain & ERP champion
You’re viewing 5 of 25 executive team members. Get the full list »

Elekta Board Members (6)

Name Representing Role Since
00000000 0ö0000000 Self Board Member 000 0000
0000000 000000ö0 Self Board Member 000 0000
000 000000 Self Board Member 000 0000
00000 000000000 Self Board Member 000 0000
00000 00000 Elekta Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Elekta Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elekta Investments & Acquisitions (24)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Philips Healthcare (Pinnacle Treatment Planning System Patent Portfolio) 03-May-2024 000000000 Buildings and Property 0000000 0
Xoft 22-Oct-2023 0000000000 00.00 Other Devices and Supplies 0000 0000
Premier Business Inter 12-Feb-2023 0000000000 Diagnostic Equipment 00000 000
Özyürek Mümessillik ve Dış Ticaret 02-Sep-2021 0000000000 Clinics/Outpatient Services 00000 000
Kaiku Health 15-May-2020 Merger/Acquisition 000.00 Other Healthcare Technology Systems 0000000 0
You’re viewing 5 of 24 investments and acquisitions. Get the full list »

Elekta Subsidiaries (5)

Company Name Industry Location Founded
ProKnow Systems Enterprise Systems (Healthcare) Stockholm, Sweden 2016
Kaiku Health Other Healthcare Technology Systems Helsinki, Finland 0000
CliniCast Enterprise Systems (Healthcare) Millbrae, CA 0000
Premier Business Inter Diagnostic Equipment Bangkok, Thailand 0000
Sociedade Avanço Distributors (Healthcare) Algueirão-Mem Martins, Portugal 0000
To view Elekta’s complete subsidiaries history, request access »

Elekta ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

17.89 | Low Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 16,216






00 of 643




Medical Devices


0. of 229




To view Elekta’s complete esg history, request access »

Elekta Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
ViewRay 05-Dec-2019 000000 0000000000 00000 Completed
  • 000000
Medical Intelligence Medizintechnik 30-Nov-2005 000000000000000000 000.00 Completed
  • 000000
ONCOlog Medical Later Stage VC 00000 Completed
To view Elekta’s complete exits history, request access »

Elekta FAQs

  • When was Elekta founded?

    Elekta was founded in 1972.

  • Who is the CEO of Elekta?

    Gustaf Salford is the CEO of Elekta.

  • Where is Elekta headquartered?

    Elekta is headquartered in Stockholm, Sweden.

  • What is the size of Elekta?

    Elekta has 4,641 total employees.

  • What industry is Elekta in?

    Elekta’s primary industry is Diagnostic Equipment.

  • Is Elekta a private or public company?

    Elekta is a Public company.

  • What is Elekta’s stock symbol?

    The ticker symbol for Elekta is EKTA B.

  • What is the current stock price of Elekta?

    As of 12-Jul-2024 the stock price of Elekta is $6.46.

  • What is the current market cap of Elekta?

    The current market capitalization of Elekta is $2.47B.

  • What is Elekta’s current revenue?

    The trailing twelve month revenue for Elekta is $1.7B.

  • Who are Elekta’s competitors?

    Varian Medical Systems, Stryker, Globus Medical, Vapotherm, and Smith & Nephew are some of the 9 competitors of Elekta.

  • What is Elekta’s annual earnings per share (EPS)?

    Elekta’s EPS for 12 months was $0.32.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »